Home » MIVT'S BIO-COMPATIBLE MEDICAL COATING TECHNOLOGIES FEATURED IN FORTUNE 500 NANOTECHNOLOGY SPECIAL REPORT; BUSINESS MAGAZINE SPOTLIGHTS PLAN TO COMMERCIALIZE PROPRIETARY DEVICE COATINGS FOR $160 BILLION DRUG DELIVERY MARKETPLACE
MIVT'S BIO-COMPATIBLE MEDICAL COATING TECHNOLOGIES FEATURED IN FORTUNE 500 NANOTECHNOLOGY SPECIAL REPORT; BUSINESS MAGAZINE SPOTLIGHTS PLAN TO COMMERCIALIZE PROPRIETARY DEVICE COATINGS FOR $160 BILLION DRUG DELIVERY MARKETPLACE
April 11, 2006
MIV Therapeutics, a leading developer of next-generation biocompatible coatings and advanced drug delivery systems for cardiovascular stents and other implantable medical devices, has been featured in the current issue of Fortune 500 Magazine, in a special section that highlights the substantial promise of its nanotechnology-based implant coating applications. Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=311656)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct